Influence of gender on 30-day outcomes of patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Hui Wang; Zhenyu Liu; Email: Pumch_lzy@163com; Shuyang Zhang; Zhujun Shen; Zhongjie Fan; Yong Zeng; Hongzhi Xie; Chonghui Wang; Xiaofeng Jin; Quan Fang; Wenling Zhu

Return

Influence of gender on 30-day outcomes of patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Author: Hui WANG ¹ ; Zhenyu LIU ² ; Email: PUMCH_LZY@163.COM. ; Shuyang ZHANG ¹ ; Zhujun SHEN ¹ ; Zhongjie FAN ¹ ; Yong ZENG ¹ ; Hongzhi XIE ¹ ; Chonghui WANG ¹ ; Xiaofeng JIN ¹ ; Quan FANG ¹ ; Wenling ZHU ¹
Author Information

1. Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730, China.
2. Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730, China
Publication Type:Journal Article
MeSH: Acute Disease; Aged; Aged, 80 and over; Cause of Death; Female; Humans; Hypertension; Male; Multivariate Analysis; Myocardial Infarction; therapy; Percutaneous Coronary Intervention; Proportional Hazards Models; Risk Factors; Sex Factors; Time Factors
From: Chinese Journal of Cardiology 2015;43(4):323-327
CountryChina
Language:Chinese
Abstract:
OBJECTIVETo investigate the impact of gender on early outcomes of patients with acute ST-segment elevation myocardial infarction (STEMI) who were treated with primary percutaneous coronary intervention (PCI) as their reperfusion strategy.
METHODSThe present study included consecutive patients with STEMI treated with primary PCI in our hospital from November 2003 to December 2012. Gender difference and predictors of 30 day all-cause death were examined among 957 patients, 197 of whom were women (20.6%). The impact of gender on 30 all-cause death was further evaluated by a propensity-matched analysis to adjust the differences in baseline characteristics between men and women.
RESULTSCompared with men, women were older ((69.4±10.2) years old vs. (60.6±12.6) years old, P<0.001), more likely to have hypertension (72.1% (142/197) vs. 54.6% (415/760), P<0.001) and diabetes (45.2% (89/197) vs. 32.4% (246/760), P = 0.001), but less likely to be treated with β-blockers (85.3% (168/197) vs. 92.0% (699/760), P = 0.006) and angiotensin converting-enzyme inhibitors/angiotensin-receptor blockers (82.2% (162/197) vs. 88.4% (672/760), P = 0.024). Symptom-to-balloon time was longer in women than in men (330 (240, 600) minutes vs. 270 (180, 450) minutes, P < 0.001). Multivariate linear regression analysis of log-transformed symptom-to-balloon time revealed that female gender was an independent predictor of longer symptom-to-balloon time (β = 0.141, 95% confidence interval (CI) 0.053-0.228, P = 0.002). Women with STEMI had higher unadjusted 30 day all-cause death (12.6% vs. 4.2%, P < 0.001) than men. Female gender independently predicted 30 day all-cause mortality both with (hazard ratio (HR) = 3.497, 95% CI 1.485-8.234, P = 0.004) and without (HR = 2.495, 95% CI 1.170-5.323, P = 0.018) the adjustment for baseline characteristics by propensity-matched analysis.
CONCLUSIONSEven with primary PCI as their reperfusion strategy, women with STEMI had higher 30 day all-cause death than men. Aggressive control of cardiovascular risk factors, adequate medical treatment and shortening of delay in reperfusion therapy might further improve the outcomes of female STEMI patients undergoing primary PCI.